ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $231,000 | -68.0% | 186,601 | -83.1% | 0.00% | -100.0% |
| Q1 2022 | $722,000 | -31.0% | 1,106,759 | +15.2% | 0.00% | 0.0% |
| Q4 2021 | $1,047,000 | -25.3% | 960,483 | +24.7% | 0.00% | 0.0% |
| Q3 2021 | $1,402,000 | -23.0% | 770,197 | +11.7% | 0.00% | -50.0% |
| Q2 2021 | $1,821,000 | -48.5% | 689,615 | -29.8% | 0.00% | -33.3% |
| Q1 2021 | $3,536,000 | +217.4% | 982,229 | +122.1% | 0.00% | +200.0% |
| Q4 2020 | $1,114,000 | +69.0% | 442,237 | +69.1% | 0.00% | 0.0% |
| Q3 2020 | $659,000 | -52.0% | 261,462 | -37.5% | 0.00% | -50.0% |
| Q2 2020 | $1,372,000 | +114.7% | 418,586 | +209.3% | 0.00% | +100.0% |
| Q4 2019 | $639,000 | +184.0% | 135,318 | +157.1% | 0.00% | – |
| Q3 2019 | $225,000 | -87.0% | 52,639 | -82.2% | 0.00% | -100.0% |
| Q2 2019 | $1,725,000 | +74.1% | 295,884 | -44.2% | 0.00% | +100.0% |
| Q4 2018 | $991,000 | -18.4% | 530,108 | +39.7% | 0.00% | 0.0% |
| Q3 2018 | $1,214,000 | +241.0% | 379,348 | +222.1% | 0.00% | – |
| Q2 2018 | $356,000 | +6.6% | 117,765 | +38.3% | 0.00% | – |
| Q1 2018 | $334,000 | +26.5% | 85,161 | +33.7% | 0.00% | – |
| Q4 2017 | $264,000 | -70.0% | 63,704 | -55.6% | 0.00% | -100.0% |
| Q3 2017 | $880,000 | +652.1% | 143,390 | +660.9% | 0.00% | – |
| Q2 2017 | $117,000 | +42.7% | 18,846 | +22.5% | 0.00% | – |
| Q4 2016 | $82,000 | -38.3% | 15,390 | -34.6% | 0.00% | – |
| Q3 2016 | $133,000 | -76.2% | 23,543 | -65.1% | 0.00% | -100.0% |
| Q4 2015 | $560,000 | +344.4% | 67,443 | +383.8% | 0.00% | – |
| Q3 2015 | $126,000 | -75.9% | 13,941 | -68.0% | 0.00% | -100.0% |
| Q2 2015 | $522,000 | -86.9% | 43,511 | -88.3% | 0.00% | -83.3% |
| Q1 2015 | $3,993,000 | +196.2% | 370,741 | +39.4% | 0.01% | +200.0% |
| Q4 2014 | $1,348,000 | +1023.3% | 265,903 | +483.3% | 0.00% | – |
| Q3 2014 | $120,000 | -63.7% | 45,588 | -44.6% | 0.00% | – |
| Q2 2014 | $331,000 | +63.9% | 82,221 | +86.5% | 0.00% | – |
| Q1 2014 | $202,000 | -52.8% | 44,096 | -55.2% | 0.00% | -100.0% |
| Q4 2013 | $428,000 | +739.2% | 98,448 | +660.9% | 0.00% | – |
| Q3 2013 | $51,000 | – | 12,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |